Ionis Pharmaceuticals Inc (IONS)
39.05
+0.59
(+1.53%)
USD |
NASDAQ |
Nov 08, 13:05
Ionis Pharmaceuticals Revenue (Annual): 787.65M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 787.65M |
December 31, 2022 | 587.37M |
December 31, 2021 | 810.46M |
December 31, 2020 | 729.26M |
December 31, 2019 | 1.123B |
December 31, 2018 | 599.67M |
December 31, 2017 | 514.18M |
December 31, 2016 | 372.78M |
December 31, 2015 | 283.70M |
December 31, 2014 | 214.16M |
December 31, 2013 | 147.28M |
December 31, 2012 | 102.05M |
December 31, 2011 | 99.09M |
December 31, 2010 | 108.47M |
December 31, 2009 | 121.60M |
December 31, 2008 | 107.19M |
December 31, 2007 | 58.34M |
Date | Value |
---|---|
December 31, 2006 | 14.86M |
December 31, 2005 | 40.13M |
December 31, 2004 | 42.62M |
December 31, 2003 | 49.99M |
December 31, 2002 | 80.18M |
December 31, 2001 | 53.27M |
December 31, 2000 | 37.26M |
December 31, 1999 | 33.90M |
December 31, 1998 | 39.20M |
December 31, 1997 | 32.70M |
December 31, 1996 | 22.70M |
December 31, 1995 | 13.00M |
December 31, 1994 | 10.10M |
December 31, 1993 | 12.10M |
December 31, 1992 | 8.70M |
December 31, 1991 | 6.30M |
December 31, 1990 | 2.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
587.37M
Minimum
2022
1.123B
Maximum
2019
807.47M
Average
787.65M
Median
2023
Revenue (Annual) Benchmarks
Biogen Inc | 9.836B |
Alnylam Pharmaceuticals Inc | 1.828B |
Biomarin Pharmaceutical Inc | 2.419B |
Rigel Pharmaceuticals Inc | 116.88M |
Apellis Pharmaceuticals Inc | 396.59M |